J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 68 (1987), 2183-2192; DOI 10.1099/0022-1317-68-8-2183
© 1987 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jentsch, K. D.
Right arrow Articles by Nickel, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jentsch, K. D.
Right arrow Articles by Nickel, P.
Agricola
Right arrow Articles by Jentsch, K. D.
Right arrow Articles by Nickel, P.

Inhibition of Human Immunodeficiency Virus Type I Reverse Transcriptase by Suramin-related Compounds

Klaus Dieter Jentsch1, Gerhard Hunsmann1, Heinz Hartmann1 and Peter Nickel2

1 Abteilung Virologie und Immunologie des Deutschen Primatenzentrums, Kellnerweg 4, D-3400 Göttingen
and2 Pharmazeutisches Institut der Universität, An der Immenburg 4, D-5300 Bonn I (Endenich), F.R.G.

Ninety analogues of suramin have been examined for their ability to inhibit the exogenous reverse transcriptase (RT) of human immunodeficiency virus type I (HIV-I). Of these compounds, 57 inhibited the poly(rC)·oligo(dG)-dependent RT activity. Three classes of dose-response curves could be discriminated. Allocation of a compound to one class did not correspond with obvious structural features. Twenty-four substances were superior to suramin in our RT inhibition assay. The RT-inhibitory activity of these compounds did not correlate with their effect against filariae or trypanosomes. Preliminary antiviral evaluation in susceptible human T cells inoculated with HIV-I demonstrated in vitro therapeutic efficacy for some compounds with lower drug-related cellular toxicity than suramin. Certain structural features relevant for the RT-inhibitory effect of these compounds were recognized. Predictions are made for the design of more effective RT inhibitors. Such compounds will help to understand the molecular mechanism of reverse transcription and might be useful in the therapy of retroviral infections.

Keywords: HIV-I, reverse transcriptase, suramin-related compounds

Received 19 January 1987; accepted 1 May 1987.


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
E. Howes, J. C. Pascall, W. Engel, and R. Jones
Interactions between mouse ZP2 glycoprotein and proacrosin; a mechanism for secondary binding of sperm to the zona pellucida during fertilization
J. Cell Sci., March 13, 2002; 114(22): 4127 - 4136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1987 by the Society for General Microbiology.